Davis Polk advised the initial purchasers in connection with a Rule 144A offering by DexCom, Inc. of $350 million aggregate principal amount of its 0.75% senior convertible notes due 2022.
Headquartered in San Diego, California, DexCom, Inc. is developing and marketing continuous glucose monitoring systems for ambulatory use by people with diabetes and by healthcare providers.
The Davis Polk corporate team included partners Alan F. Denenberg and Stephen Salmon and associates Max Brunner and Randy Li. The tax team included partner Rachel D. Kleinberg and associates Catherine L. Chu and Liang Zhang. Counsel Michelle Ontiveros Gross and associate Jason J. Bang provided intellectual property and technology advice. Members of the Davis Polk team are based in the Northern California and New York offices.